Yarbrough Capital LLC Has $87,000 Stake in agilon health, inc. (NYSE:AGL)

Yarbrough Capital LLC lessened its stake in shares of agilon health, inc. (NYSE:AGL) by 43.0% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 20,130 shares of the company’s stock after selling 15,203 shares during the quarter. Yarbrough Capital LLC’s holdings in agilon health were worth $87,000 as of its most recent filing with the SEC.

A number of other large investors have also recently added to or reduced their stakes in the stock. Ieq Capital LLC acquired a new stake in shares of agilon health in the fourth quarter worth $26,000. Signaturefd LLC lifted its position in agilon health by 143.0% during the 4th quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock worth $27,000 after acquiring an additional 8,467 shares during the last quarter. Humankind Investments LLC acquired a new position in agilon health during the 4th quarter worth $30,000. Raymond James Financial Inc. bought a new stake in agilon health during the fourth quarter valued at about $33,000. Finally, Cerity Partners LLC acquired a new stake in shares of agilon health in the fourth quarter valued at about $34,000.

agilon health Stock Performance

NYSE:AGL opened at $2.15 on Friday. The firm has a market capitalization of $890.00 million, a PE ratio of -2.29 and a beta of 0.14. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health, inc. has a 12-month low of $1.50 and a 12-month high of $7.73. The firm has a 50-day moving average price of $3.57 and a 200 day moving average price of $3.20.

agilon health (NYSE:AGL) last issued its earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.04. The business had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.50 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. agilon health’s quarterly revenue was down 4.5% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.02) EPS. Research analysts anticipate that agilon health, inc. will post -0.59 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on AGL shares. JMP Securities reissued a “market perform” rating on shares of agilon health in a research report on Monday, April 28th. Sanford C. Bernstein upgraded agilon health from a “market perform” rating to an “outperform” rating and upped their price target for the stock from $3.30 to $8.50 in a report on Tuesday, April 8th. Needham & Company LLC reissued a “hold” rating on shares of agilon health in a research report on Friday, March 21st. Citigroup upgraded shares of agilon health from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $3.25 to $5.00 in a research note on Friday, April 25th. Finally, Cowen reiterated a “hold” rating on shares of agilon health in a research note on Tuesday, April 15th. Two analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, agilon health currently has a consensus rating of “Hold” and an average price target of $4.79.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.